Pyrazole and its derivatives constitutes an important class of heterocyclic compounds and has received widespread attention due to their diverse pharmacological activities such as anti-inflammatory -- analgesic,\[[@ref1][@ref2][@ref3]\] antimicrobial,\[[@ref4][@ref5]\] anticancer,\[[@ref6][@ref7]\] antihypertensive,\[[@ref8][@ref9]\] antidiabetic,\[[@ref10][@ref11]\] antidepressant-anticonvulsant,\[[@ref12][@ref13]\] etc. There are numerous pyrazole containing drugs approved by United States Food and Drug Administration for appropriate therapeutic indications some of which includes celecoxib, lonazolac, crizotinib, etc. [Figure 1](#F1){ref-type="fig"} presents some of the pyrazole derived therapeutic agents and represent the molecular varsity of pyrazole nucleus. However, some recent studies reported the potential of pyrazole derivatives as dual anti-inflammatory - antimicrobial agents.\[[@ref14][@ref15]\] In view of all these facts and as the continuation of our work on the synthesis of pyrazole derivatives,\[[@ref16][@ref17][@ref18]\] we undertook the one pot synthesis of naphthyl incorporated pyrazole compounds and their antimicrobial screening.

![Chemical structures of various pyrazole containing drugs](JPBS-6-253-g001){#F1}

Materials and Methods {#sec1-1}
=====================

Melting points were determined by the open capillary method with electrical melting point apparatus and are uncorrected. IR spectra were recorded as KBr (pallet) on Nicolet, Protege 460 Fourier transform infrared spectroscopy (FTIR) spectrophotometer and ^1^H and ^13^C-NMR spectra recorded on Bruker DPX 300 MHz spectrophotometer using DMSO-d~6~ or CDCl~3~ as a NMR solvent. Tetramethylsilane was used as internal standard and chemical shift data reported in parts per million (in ppm) where s, broad singlet (bs), d, t, and m designated as singlet, bs, doublet, triplet, and multiplet, respectively. Mass spectra-electrospray ionization (MS-ESI) were recorded on a JEOL-AccuTOF JMS-T100LS mass spectrometer with a direct analysis in real time and elemental analysis on C, H, N Analyzer Perkin Elmer 2400. Thin layer chromatography (TLC) was performed to monitor progress of the reaction and purity of the compounds, spot being located under iodine vapor or ultraviolet-light. The synthesis of compounds was achieved as per scheme outlined in [Figure 2](#F2){ref-type="fig"}.

![Route of synthesis for compounds (4a--4k) as Scheme 1. Reagent and conditions: (a) Phenyl hydrazine, abs. EtOH, reflux (b) DMF/POCl~3~, 55--60°C, warm (c) aromatic amines, NaBH~4~/I~2~, MeOH, stirring](JPBS-6-253-g002){#F2}

Synthesis of 1-\[1-(naphthalen-2-yl) ethylidene\]-2-phenylhydrazine (2) {#sec2-1}
-----------------------------------------------------------------------

A mixture of 2-acetylnaphthalene 1 (1.7 g or 0.01 mol) and phenyl hydrazine (0.012 mol) was refluxed in round bottom flask containing absolute ethanol (30 ml) for 2.0 h in presence of few drops of acetic acid. The content of the flask was cooled to give solid product which was filtered, washed with water, dried and recrystallized from ethanol as a yellow crystalline solid. The purity of compound was checked by TLC using (thin layer chromatography) (T:E:F, 5:4:1) as mobile phase.

Yield 89%; M.P. 165°C; IR (KBr)/cm: 3348 (NH), 1621 (C=N), 1588 (C=C). ^1^H-NMR (300 MHz, DMSO-d~6~): δ 2.35 (s, 3H, CH~3~), 7.24-7.33 (m, 4H, Ar-H), 7.42-7.49 (m, 2H, Ar-H), 7.79-7.86 (m, 5H, Ar-H), 7.99 (s, 1H, Ar-H), 8.12-8.22 (d, 1H, Ar-H, *J* = 8.7 Hz), 10.7 (bs, 1H, NH). C, H, N analysis (C~18~H~16~N~2~, calculated/found %); C 83.04/83.39, H 6.19/6.15, N 10.76/10.82.

Synthesis of 3-(naphthalen-2-yl)-1-phenyl-1*H*-pyrazole-4-carbaldehyde (3) {#sec2-2}
--------------------------------------------------------------------------

To a cold solution of naphthyl hydrazones 2 (3.9 g or 0.015 mol) in DMF (25 ml) was added POCl~3~ (5 ml, 39.5 mmol) and resulting mixture was stirred at 55-60°C for 5-6 h. Then the mixture was cooled to room temperature and poured in to ice-cold water. A saturated solution of sodium bicarbonate was added to neutralize the solution. The precipitate so formed was filtered, washed with water, dried and recrystallized from ethanol as a creamy-yellowish/yellowish white crystalline solid.

Yield 68%; M.P. 148°C; IR (KBr)/cm: 1676 (C = O), 1603 (C=N), 1591 (C=C). ^1^H-NMR (300 MHz, DMSO-d~6~): δ 7.38--7.43 (m, 1H, Ar-H), 7.51-7.56 (m, 4H, Ar-H), 7.82-7.85 (m, 3H, Ar-H), 7.89--7.97 (m, 4H, Ar-H), 8.33 (s, 1H, Ar-H), 10.18 (s, 1H, CHO). ^13^C-NMR (DMSO-d~6~, 75 MHz) δ: 119.2, 121.8, 124.5, 125.2, 125.9, 127.1, 128.3, 128.8, 130.2, 131.8, 136.4, 137.9, 140.0, 157.9, 183.5 (CHO). MS (ESI): M/z 298 (M)^+^, 299 (M + 1), 270 (M-28). C, H, N analysis (C~20~H~14~N~2~O, calculated/found %); C 62.68/62.49, H 3.16/3.14, N 7.31/7.35.

General procedure for the synthesis of compounds (4a-4k) {#sec2-3}
--------------------------------------------------------

To a solution of 3-(naphthalen-2-yl)-1-phenyl-1*H*-pyrazole-4-carbaldehyde 3 (0.29 g, 1.0 mmol) in 10 ml of methanol, substituted aniline (1.2 mmol) was added and then 50 mg iodine (0.05 g, 0.4 mmol) was added with stirring at room temperature. To the stirred solution 55 mg of sodium borohydride (0.055 g, 1.4 mmol) was added slowly, stirring was continued for 3-6 h. The precipitate was formed which was filtered, washed with water, dried and recrystallized from ethanol/methanol to give crystalline product (4a-4k). The progress of reaction and purity of the compound was checked by (TLC), using benzene: acetone (9.5:0.5) as mobile phase.

4-(Anilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4a) {#sec2-4}
------------------------------------------------------------

IR (KBr)/cm: 3402 (N-H), 1620 (C=N), 1595 (C=C), 1029 (C-N), 754 (C-Cl). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.89 (s, 1H, NH, D~2~O-exchangeble), 4.49 (s, 2H, CH~2~), 6.59-6.62 (d, 2H, Ar-H, *J* = 8.2 Hz), 6.89-7.01 (m, 3H, Ar-H), 7.27-7.35 (m, 2H, Ar-H), 7.48-7.54 (m, 3H, Ar-H), 7.79-8.01 (m, 5H, Ar-H), 8.06-8.10 (m, 2H, Ar-H), 8.31 (s, 1H, Ar-H). ^13^C-NMR (CDCl~3~, 75 MHz) δ: 38.3 (CH~2~), 114.8, 116.6, 119.2, 120.4, 121.5, 124.2, 125.8, 126.9, 127.1, 128.3, 128.9, 130.9, 137.9, 138.6, 139.7, 143.8, 149.6. MS (ESI) m/z: 375 (M)^+^, 376 (M + 1). C, H, N analysis (%, calculated/found); C, 83.17/82.51, H 5.64/5.58, N 11.19/11.23.

4-(4-Chloroanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4b) {#sec2-5}
--------------------------------------------------------------------

IR (KBr)/cm: 3410 (N-H), 1625 (C=N), 1606 (C=C), 1032 (C-N). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.82 (s, 1H, NH, D~2~O-exchangeble), 4.46 (bs, 2H, CH~2~), 6.58-6.62 (d, 2H, Ar-H, *J* = 8.0 Hz), 7.13-7.17 (d, 2H, Ar-H, *J* = 7.8 Hz), 7.25-7.31 (m, 2H, Ar-H), 7.44-7.49 (m, 3H, Ar-H), 7.75--7.92 (m, 5H, Ar-H), 8.00-8.04 (m, 2H, Ar-H), 8.24 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 76.18/77.05, H 4.92/4.96, N 10.25/10.32.

3-(2-Naphthyl)-1-phenyl-4-(4-toluidinomethyl)-1*H*-pyrazole (4c) {#sec2-6}
----------------------------------------------------------------

IR (KBr)/cm: 3410 (N--H), 1619 (C=N), 1597 (C=C), 1028 (C-N). ^1^H-NMR (300 MHz, CDCl~3~): δ 2.26 (s, 3H, CH~3~), 3.85 (s, 1H, NH, D~2~O-exchangeble), 4.45 (s, 2H, CH~2~), 6.62-6.64 (d, 2H, Ar-H, *J* = 8.4 Hz), 7.01-7.04 (d, 2H, Ar-H, *J* = 7.8 Hz), 7.25-7.31 (m, 2H, Ar-H), 7.44--7.49 (m, 3H, Ar-H), 7.75-7.92 (m, 5H, Ar-H), 8.00--8.04 (m, 2H, Ar-H), 8.24 (s, 1H, Ar-H). ^13^C-NMR (CDCl~3~, 75 MHz) δ: 20.7 (CH~3~), 38.8 (CH~2~), 114.7, 119.4, 120.1, 121.8, 125.2, 125.9, 127.5, 128.1, 128.7, 129.6, 130.5, 131.7, 137.4, 138.5, 140.3, 144.8, 149.8. MS (ESI) m/z: 389 (M)^+^. C, H, N analysis (%, calculated/found); C 83.26/83.68, H 5.95/6.01, N 10.79/10.86.

4-(4-Bromoanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4d) {#sec2-7}
-------------------------------------------------------------------

IR (KBr)/cm: 3420 (N-H), 1639 (C=N), 1590 (C=C), 1031 (C--N). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.88 (s, 1H, NH, D~2~O-exchangeble), 4.50 (s, 2H, CH~2~), 6.64-6.65 (d, 2H, Ar-H, *J* = 8.6 Hz), 7.12-7.15 (d, 2H, Ar-H, *J* = 8.0 Hz), 7.29-7.35 (m, 2H, Ar-H), 7.43--7.47 (m, 3H, Ar-H), 7.77--7.96 (m, 5H, Ar-H), 8.01-8.04 (m, 2H, Ar-H), 8.27 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 68.73/69.07, H 4.44/4.51, N 9.25/9.33.

4-(3-Chloroanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4e) {#sec2-8}
--------------------------------------------------------------------

IR (KBr) cm^-1^: 3416 (N--H), 1629 (C=N), 1589 (C=C), 1047 (C--N). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.88 (s, 1H, NH, D~2~O-exchangeble), 4.51 (s, 2H, CH~2~), 6.60--6.64 (m, 2H, Ar-H), 6.94-6.97 (m, 1H, Ar-H), 7.05-7.08 (m, 1H, Ar-H), 7.21-7.26 (m, 2H, Ar-H), 7.42--7.53 (m, 3H, Ar-H), 7.80--7.98 (m, 5H, Ar-H), 8.04--8.09 (m, 2H, Ar-H), 8.30 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 76.18/76.65, H 4.92/4.97, N 10.25/10.30.

4-(4-Methoxyanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4f) {#sec2-9}
---------------------------------------------------------------------

IR (KBr)/cm^-1^: 3389 (N--H), 1610 (C=N), 1593 (C=C), 1027 (C--N), 751 (C--Cl). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.76 (s, 3H, OCH~3~), 3.83 (s, 1H, NH, D~2~O-exchangeble), 4.40 (bs, 2H, CH~2~), 6.59-6.62 (d, 2H, Ar-H, *J* = 8.4 Hz), 6.93-6.96 (d, 2H, Ar-H, *J* = 7.8 Hz), 7.27-7.33 (m, 2H, Ar-H), 7.45-7.53 (m, 4H, Ar-H), 7.79-7.95 (m, 4H, Ar-H), 8.02-8.07 (m, 2H, Ar-H), 8.28 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 79.97/78.28, H 5.72/5.75, N 10.36/10.42.

4-(4-Fluoroanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4g) {#sec2-10}
--------------------------------------------------------------------

IR (KBr)/cm: 3410 (N--H), 1635 (C=N), 1596 (C=C), 1034 (C--N), 728 (C--Cl). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.86 (s, 1H, NH, D~2~O-exchangeble), 4.47 (s, 2H, CH~2~), 6.63-6.66 (d, 2H, Ar-H, *J* = 8.4 Hz), 7.07-7.12 (m, 2H, Ar-H), 7.30-7.36 (m, 2H, Ar-H), 7.43--7.50 (m, 3H, Ar-H), 7.68--7.72 (m, 1H, Ar-H), 7.809-7.94 (m, 4H, Ar-H), 8.03-8.08 (m, 2H, Ar-H), 8.27 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 79.37/79.11, H 5.12/5.10, N 10.68/10.73.

3-(2-Naphthyl)-4-(4-nitroanilinomethyl)-1-phenyl-1*H*-pyrazole (4h) {#sec2-11}
-------------------------------------------------------------------

IR (KBr)/cm: 3421 (N--H), 1632 (C=N), 1601 (C=C), 1039 (C--N), 765 (C--Cl). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.84 (s, 1H, NH, D~2~O-exchangeble), 4.51 (s, 2H, CH~2~), 6.60--6.63 (d, 2H, Ar-H, *J* = 8.4 Hz), 7.01-7.06 (m, 2H, Ar-H), 7.30-7.36 (m, 2H, Ar-H), 7.44-7.52 (m, 3H, Ar-H), 7.79--7.94 (m, 5H, Ar-H), 8.01-8.06 (m, 2H, Ar-H), 8.24 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 74.27/74.51, H 4.79/4.82, N 13.32/13.37.

3-(2-Naphthyl)-1-phenyl-4-(3-toluidinomethyl)-1*H*-pyrazole (4i) {#sec2-12}
----------------------------------------------------------------

IR (KBr)/cm: 3426 (N--H), 1612 (C=N), 1598 (C=C), 1039 (C--N). ^1^H-NMR (300 MHz, CDCl~3~): δ 2.25 (s, 3H, CH~3~), 3.84 (s, 1H, NH, D~2~O-exchangeble), 4.51 (bs, 2H, CH~2~), 6.58--6.61 (m, 2H, Ar-H), 6.89-6.93 (m, 1H, Ar-H), 7.01--7.04 (m, 1H, Ar-H), 7.25--7.29 (m, 2H, Ar-H), 7.42--7.54 (m, 3H, Ar-H), 7.78--7.96 (m, 5H, Ar-H), 8.01--8.05 (m, 2H, Ar-H), 8.27 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 83.26/83.04, H 5.95/5.94, N 10.79/10.83.

4-(3-Chloro-4-fluoroanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4j) {#sec2-13}
-----------------------------------------------------------------------------

IR (KBr)/cm: 3432 (N--H), 1636 (C=N), 1604 (C=C), 1035 (C--N). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.85 (s, 1H, NH, D~2~O-exchangeble), 4.52 (s, 2H, CH~2~), 6.63--6.66 (m, 2H, Ar-H), 6.89--6.93 (m, 1H, Ar-H), 7.01--7.04 (m, 1H, Ar-H), 7.25--7.29 (m, 2H, Ar-H), 7.42--7.54 (m, 3H, Ar-H), 7.78--7.96 (m, 4H, Ar-H), 8.01--8.05 (m, 2H, Ar-H), 8.27 (s, 1H, Ar-H). C, H, N Analysis (%, calculated/found); C 72.98/72.74, H 4.48/4.50, N 9.82/8.87.

4-(3,4-Dichloroanilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4k) {#sec2-14}
------------------------------------------------------------------------

IR (KBr)/cm: 3438 (N--H), 1620 (C=N), 1603 (C=C), 1033 (C--N). ^1^H-NMR (300 MHz, CDCl~3~): δ 3.89 (s, 1H, NH, D~2~O-exchangeble), 4.60 (s, 2H, CH~2~), 6.62--6.65 (m, 2H, Ar-H), 6.90--6.93 (m, 1H, Ar-H), 7.03--7.07 (m, 1H, Ar-H), 7.25--7.31 (m, 2H, Ar-H), 7.41--7.46 (m, 2H, Ar-H), 7.80--7.97 (m, 5H, Ar-H), 8.02--8.06 (m, 2H, Ar-H), 8.24 (s, 1H, Ar-H). C, H, N analysis (%, calculated/found); C 70.28/70.14, H 4.31/4.28, N 9.46/9.50.

Antimicrobial activity {#sec2-15}
----------------------

The newly synthesized compounds were screened for their antifungal and antibacterial activities against the test organism viz. *Candida albicans* Microbial Type Culture Collection (MTCC)-183, *Aspergillus niger* MTCC 281, *Aspergillus flavus* MTCC 277, *Escherichia coli* National Collection of Type Cultures (NCTC) 10418, *Staphylococus aureus* NCTC 6571, *Pseudomonas aeruginosa* NCTC 10662 in DMSO by cup plate method.\[[@ref19][@ref20]\] Potato dextrose agar and nutrient agar were used as culture medium for antifungal and antibacterial activity respectively. Using an agar punch, wells were made on these seeded agar plates and dilution of 500 μg/ml of test compounds in DMSO was added into each well, labeled previously. A control was also prepared using solvent DMSO. The petri plate were prepared and maintained at 30° for 72 h for fungi and at 37°C for 24 h for bacteria. Each experiment was repeated twice and the average of the two independent determinations was recorded. Antimicrobial activity was determined by measuring zone of inhibition and results were reported as percentage inhibition and calculated as 100 (C − T)/C, where C is the average diameter of fungal or bacterial growth on the control plate and T is the average diameter of fungal or bacterial growth on test plate. Activity of each compound was compared with standard fluconazole (100 μg/ml) for antifungal and ciprofloxacin (100 μg/ml) for antibacterial activity. Results of antimicrobial activity have been summarized in [Table 1](#T1){ref-type="table"}.

###### 

Antifungal and antibacterial activity data of 4-(substituted-anilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4a--4k)

![](JPBS-6-253-g003)

Results and Discussion {#sec1-2}
======================

Chemistry {#sec2-16}
---------

The various secondary amines (4a--4k) were synthesized by direct reductive amination using NaBH~4~ in the presence of I~2~ as reducing agent.\[[@ref16]\] The reaction was carried out by simply stirring 1.0 equivalent of pyrazolyl carboxaldehyde 3 and 1.2 equivalents of aromatic amine in methanol in the presence of the NaBH~4~/I~2~ reagent. The iodine catalyzed the *in situ* formation of an imine at room temperature that was ultimately reduced *in situ* to the secondary amine by NaBH~4~. The structures of all the newly synthesized compounds were elucidated on the basis of IR and ^1^H-NMR data. In addition, ^13^C-NMR and mass spectral data of some of the compounds was also carried out in support of these proposed structures. Elemental analysis of compounds was found to be satisfactory and within the range of ± 0.4%. In the FTIR spectra of all the compounds (4a--4k) the absorption bands were observed in the range of 1589--1606/cm corresponding to C=C. The NH stretching and C--N stretching vibrations of --CH~2~NH-- were observed in range of 3389--3420/cm and 1027--1047/cm, respectively. The functional group transformation of --CHO of compound 3 into --CH~2~NH-- in compounds 4a--4k was established on the basis of IR, ^1^H, ^13^C NMR, and mass spectral data. In FTIR, the characteristic carbonyl C=O stretching band, which was observed at 1676/cm in compound 3 disappeared in FTIR spectra of compounds (4a--4k). In the ^1^H-NMR spectra of compound three aldehydic proton resonated as a singlet at δ value 10.18, which disappeared in spectra of compounds 4a--4k and a new signal was observed at high up field δ value 4.40--4.52 integrating for two protons. The signal due to the NH proton was observed at δ value 3.82--3.89. The methylene group of --CH~2~NH-- appeared as a singlet and/or bs due to coupling effect of NH proton whereas the NH signal was observed as a bs. Furthermore, in the ^13^C-NMR spectrum of the compound 3 the signal due to the carbonyl carbon was observed at δ value 183.5 ppm. No carbonyl carbon signal was found in the ^13^C-NMR spectra of two prototype compounds 4a and 4c and a new signal due to methylene carbon of --CH~2~NH-- appeared at δ value 38.3 and 38.8, respectively. The above spectral analysis suggested the successful reductive amination of pyrazole carbaldehyde three. The physicochemical data of compounds (4a--4k) is presented in [Table 2](#T2){ref-type="table"}. The fact was further supported by MS (ESI) spectra of selected compounds 4a and 4c. In ^1^H-NMR, the protons of naphthalene and phenyl rings were observed in aromatic region as multiplets due to coupling and overlapping of signals. While a singlet integrating for one proton appeared at δ value 8.24--8.31 arising due to H-5 proton of the pyrazole nucleus. These data are in agreement with structures assigned to the compounds (4a--4k). The spectral detail of individual compound (4a--4k) has been given in experimental section.

###### 

Physicochemical data of 4-(substituted-anilinomethyl)-3-(2-naphthyl)-1-phenyl-1*H*-pyrazole (4a-4k)

![](JPBS-6-253-g004)

Antifungal activity {#sec2-17}
-------------------

All the 1*H*-pyrazolyl amines derivatives (4a--4k) of Scheme 1 displayed variable growth inhibitory effects against the test organism at concentration of 500 μg/ml in DMSO as shown in [Table 1](#T1){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}. Among the series of compounds (4a--4k), compounds 4b, 4d, 4e, and 4g showed good antifungal activity against *C. albicans*. The growth inhibitory effect of compounds (4a--4k) was more prominent against the fungal strain *A. niger* MTCC 281 and *A. flavus* MTCC 277. In this series compound 4e, 4g, 4j, and 4k, showed excellent antifungal activity against the fungal strain *A. niger* MTCC 281 and *A. flavus* MTCC 277 (% inhibition in the range of 47.7--58.9). While, rest of the compounds such as 4a, 4c, 4d, 4f, and 4i, displayed moderate antifungal activity. Only one derivative 4h expressed weak antifungal activity.

![Bar diagram showing antifungal activity of compounds (4a--4k) against fungal strain *Candida albicans, Aspergillus niger and Aspergillus flavus*](JPBS-6-253-g005){#F3}

Antibacterial activity {#sec2-18}
----------------------

All the 1*H*-pyrazolyl amine derivatives (4a--4k) of Scheme 1 were also evaluated for antibacterial activity against the strains *E. coli* NCTC 10418, *S. aureus* NCTC 6571, *P. aeruginosa* NCTC 10662 at concentration of 500 μg/ml in DMSO by cup plate method. Results of antibacterial study are presented in [Table 1](#T1){ref-type="table"} and careful examination of [Table 1](#T1){ref-type="table"} and [Figure 4](#F4){ref-type="fig"} revealed that most of molecules of Scheme 1 (4a--4k) exhibited moderate to weak antibacterial activity against the test organism *E. coli* NCTC 10418, *S. aureus* NCTC 6571 at the concentration of 500 μg/ml. Compounds were completely inactive against the strain *P. aeruginosa* NCTC 10662.

![Bar diagram showing antibacterial activity of compounds (4a--4k) against bacterial strain *Escherichia coli, Staphylococus aureus and Pseudomonas auroginosa*](JPBS-6-253-g006){#F4}

Conclusion {#sec1-3}
==========

In the present study, one-pot synthesis 4- (substituted- anilinomethyl-3-(2-naphthyl)-1-phenyl-1H-pyrazoles (4a--4k) using NaBH4/I~2~ as reducing agent. The current process offers advantages such as good yield, simple procedure, use easily available reagents, etc., The antimicrobial screening of these compounds against a panel of bacterial and fungal strains showed that compounds were more active toward the fungal strains compared to the bacterial strains, In this series compound 4e, 4g, 4j, and 4k, showed excellent antifungal activity against the fungal strain *A. niger* MTCC 281 and *A. flavus* MTCC 277 (47.7--58.9% inhibition).
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